A carregar...
The promise of ketamine for treatment-resistant depression: current evidence and future directions
Major depressive disorder (MDD) is one of the most disabling diseases worldwide and is a significant public health threat. Current treatments for MDD primarily consist of monoamine-targeting agents and have limited efficacy. However, the glutamate neurotransmitter system has recently come into focus...
Na minha lista:
| Publicado no: | Ann N Y Acad Sci |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4447578/ https://ncbi.nlm.nih.gov/pubmed/25649308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/nyas.12646 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|